Prevalence of human papillomavirus in adolescent girls before reported sexual debut

Journal of Infectious Diseases

Volumn 210, Issue 6, 2014, Pages 837-845

  Houlihan, Catherine F ^a,b   De Sanjosé, Silvia ^c,d   Baisley, Kathy ^a   Changalucha, John ^e   Ross, David A ^a   Kapiga, Saidi ^a,b   Godinez, Jose M ^c   Bozicevic, Ivana ^f   Hayes, Richard J ^a   Watson Jones, Deborah ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b National Institute for Medical Research   (Tanzania)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d Centro de Investigación Biomédica en Red de Cáncer CIBERONC University of Barcelona   (Spain)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^f UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Human papillomavirus; Prevalence; Sexual debut; Sub Saharan Africa

Indexed keywords

ADOLESCENT; ADOLESCENT SEXUAL BEHAVIOR; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; HYGIENE; INTRAVAGINAL CLEANSING; NORMAL HUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SEXUAL DEBUT; SMEAR; TANZANIA; VAGINA SWAB; VIRUS DETECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; PREVALENCE; SEXUAL DEBUT; SUB-SAHARAN AFRICA;

ADOLESCENT; FEMALE; GENOTYPE; HUMANS; HYGIENE; INTERVIEWS AS TOPIC; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEXUAL BEHAVIOR; TANZANIA; VAGINA;

EID: 84907379852     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu202     Document Type: Conference Paper

References (50)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010.
2. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009; 10:321-2.
3. de Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7:453-9.
4. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008; 43:S5-25, S25.e1-41.
5. Giuliano A, Harris R. Incidence, prevalence, and clearance of typespecific human papillomavirus infections: the young women's health study. J Infect Dis 2002; 186:462-9.
6. Weaver B, Tu W, Shew M, et al. Acquisition of first human papillomavirus infection related to first vaginal intercourse and other sexually transmitted infections in adolescent women. J Adolesc Health 2011; 48:S11-2.
7. Winer R, Lee S, Hughes J. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157:218-26.
8. Hildesheim A, Herrero R. Human papillomavirus vaccine should be given before sexual debut for maximum benefit. J Infect Dis 2007; 196:1431-2.
9. Rylander E, Ruusuvaara L, AlmströmerMW, Evander M,Wadell G. The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse. Obstet Gynecol 1994; 83:735-7.
10. WHO. WHO position on HPV vaccines. Vaccine 2009; 27:7236-7.
11. Watson-Jones D, Baisley K, Ponsiano R, et al. Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis 2012; 206:678-86.
12. Andersson-Ellström A, Hagmar BM, Johansson B, Kalantari M, Wärleby B, Forssman L. Human papillomavirus deoxyribonucleic acid in cervix only detected in girls after coitus. Int J STD AIDS 1996; 7:333-6.
13. Kjaer SK, Chackerian B, van der Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001; 10:101-6.
14. Fairley CK, Chen S, Tabrizi SN, Leeton K, Quinn MA, Garland SM. The absence of genital human papillomavirus DNA in virginal women. Int J STD AIDS 1992; 3:414-7.
15. Winer RL, Feng Q, Hughes JP, O'Reilly S, Kiviat NB, Koutsky LA. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008; 197:279-82.
16. Plummer ML, Ross DA, Wight D, et al. "A bit more truthful": the validity of adolescent sexual behaviour data collected in rural northern Tanzania using five methods. Sex Transm Infect 2004; 80:ii49-56.
17. Upchurch DM, Lillard LA, Aneshensel CS, Fang Li N. Inconsistencies in reporting the occurrence and timing of first intercourse among adolescents. J Sex Res 2002; 39:197-206.
18. Lees S, Cook C, Vallely A, et al. Comparison of sexual behavior data collected using a coital diary and a clinic-based interview during a microbicide pilot study in Mwanza, Tanzania. Sex Transm Dis 2010; 37:497-501.
19. Doyle AM, Ross DA, Maganja K, et al. Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial. PLOS Med 2010; 7:e1000287.
20. Plummer M, Wight D. Young people's lives and sexual relationships in rural Africa: findings from a large qualitative study in Tanzania. Maryland, USA: Lexington Books, 2011.
21. Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 2007; 298:743-53.
22. Bosch FX, Qiao Y-L, Castellsagué X. CHAPTER 2 The epidemiology of human papillomavirus infection and its association with cervical cancer. Int J Gynecol Obstet 2006; 94:S8-21.
23. Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. Perinatal transmission of human papilomavirus DNA. Virol J 2009; 6:83.
24. Castellsagué X, Drudis T, Cañadas MP, et al. Human papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. BMC Infect Dis 2009; 9:74.
25. Marrazzo JM, Koutsky LA, Stine KL, et al. Genital human papillomavirus infection in women who have sex with women. J Infect Dis 1998; 178:1604-9.
26. Francis SC, Baisley K, Lees SS, et al. Vaginal practices among women at high risk of HIV infection in Uganda and Tanzania: recorded behaviour from a daily pictorial diary. Thorne C, editor. PLOS ONE Public Library of Science; 2013; 8:e59085.
27. Martin Hilber A, Hull TH, Preston-Whyte E, et al. A cross cultural study of vaginal practices and sexuality: implications for sexual health. Soc Sci Med 2010; 70:392-400.
28. Lees S, Zalwango F, Andrew B, et al. Understanding motives for intravaginal practices amongst Tanzanian and Ugandan women at high risk of HIV infection: the embodiment of social and cultural norms and well-being. Soc Sci Med Elsevier Ltd; 2014; 102: 165-73.
29. McClelland RS, Lavreys L, Hassan WM, Mandaliya K, Ndinya-Achola JO, Baeten JM. Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS 2006; 20:269-73.
30. Tsai C, Shepherd B, Vermund S. Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol 2009; 200:1-17.
31. Tarkowski TA, Koumans EH, Sawyer M, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004; 189:46-50.
32. Winer RL, Hughes JP, Feng Q, et al. Detection of genital HPV types in fingertip samples from newly sexually active female university students. Cancer Epidemiol Biomarkers Prev 2010; 19:1682-5.
33. Strauss S, Sastry P, Sonnex C, Edwards S, Gray J. Contamination of environmental surfaces by genital human papillomaviruses. Sex Transm Infect 2002; 78:135-9.
34. Roden RBS, Lowy DR, Schiller JT. Papillomavirus is resistant to desiccation. J Infect Dis 1997; 176:1076-9.
35. Watson-Jones D, Baisley K, Brown J, et al. High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects. Sex Transm Infect 2013; 89:358-65.
36. Dartell M, Rasch V, Kahesa C, et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study. Sex Transm Dis 2012; 39:201-8.
37. Crucitti T, Jespers V, Mulenga C, Khondowe S, Vandepitte J, Buvé A. Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia. PLOS ONE 2011; 6:e16310.
38. Low N, Chersich MF, Schmidlin K, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLOS Med 2011; 8:e1000416.
39. Brown D, Shew M, Qadadri B, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005; 191:182-92.
40. Richardson H, Abrahamowicz M, Tellier P-P, et al. Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev 2005; 14:1149-56.
41. Anemona A, Plummer M, Chilongani J, et al. The acceptability and quality of self-administered vaginal swabs among adolescents in rural Tanzania. In: The XIV International AIDS Conference, 2002.
42. Safaeian M, Kiddugavu M, Gravitt PE, et al. Comparability of selfcollected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sex Transm Dis 2007; 34:429-36.
43. Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005; 81:207-12.
44. Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol Biomarkers Prev 2008; 17:1248-54.
45. Schiffman M, Wheeler CM, Dasgupta A, Solomon D, Castle PE. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears. Am J Clin Pathol 2005; 124: 722-32.
46. UNICEF Country Information Tanzania. http://www.unicef.org/infobycountry/ tanzania-statistics.html. Accessed 4 April 2013.
47. Minnis AM, Steiner MJ, Gallo MF, et al. Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol 2009; 170:918-24.
48. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 1999; 179:16-24.
49. Bastien S, Mason-Jones AJ, De Koker P, Mmbaga EJ, Ross DA, Mathews C. Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review. Int J STD AIDS 2012; 23:761-6.
50. Belinson JL, Hu S, Niyazi M, et al. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer 2010; 127:1151-7.